Key result
The MyCor telemonitoring program significantly improved quality of life scores from 5.5 at baseline to 6.3 at 18 weeks (p<0.01) in patients with coronary heart disease.
Why the study?
Does the MyCor telemonitoring programme improve adherence and quality of life in patients with coronary heart disease?
Population
25 patients with coronary heart disease (CHD), mean age 63 years.
Design
Cohort
Follow-up
4.5 months (18 weeks)
Authors
Loading...
Associated with QoL gains in CHD cohort; hypothesis-generating, requiring RCTs before practice change.
Does the MyCor telemonitoring programme improve adherence and quality of life in patients with coronary heart disease?
Absolute Event Rate: 6.3% vs 5.5%
p-value: p=<0.01
The MyCor telemonitoring program is feasible, highly accepted, and associated with improved quality of life and high adherence in patients with coronary heart disease over 4.5 months.
Woess et al. (2015) studied Coronary heart disease (CHD) (n=25). MyCor telemonitoring programme was evaluated on Quality of life (MacNew questionnaire) (p=<0.01). The MyCor telemonitoring program significantly improved quality of life scores from 5.5 at baseline to 6.3 at 18 weeks (p<0.01) in patients with coronary heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: